[HTML][HTML] The state of complement in COVID-19
Hyperactivation of the complement and coagulation systems is recognized as part of the
clinical syndrome of COVID-19. Here we review systemic complement activation and local …
clinical syndrome of COVID-19. Here we review systemic complement activation and local …
Healing after COVID-19: are survivors at risk for pulmonary fibrosis?
LT McDonald - … Journal of Physiology-Lung Cellular and …, 2021 - journals.physiology.org
The novel SARS-CoV-2 coronavirus, which is responsible for COVID-19 disease, was first
reported in Wuhan, China, in December of 2019. The virus rapidly spread, and the World …
reported in Wuhan, China, in December of 2019. The virus rapidly spread, and the World …
[HTML][HTML] Lung fibrosis after COVID-19: treatment prospects
At the end of 2019, a highly contagious infection began its ominous conquest of the world. It
was soon discovered that the disease was caused by a novel coronavirus designated as …
was soon discovered that the disease was caused by a novel coronavirus designated as …
[HTML][HTML] Sequelae, persistent symptomatology and outcomes after COVID-19 hospitalization: the ANCOHVID multicentre 6-month follow-up study
Á Romero-Duarte, M Rivera-Izquierdo… - BMC medicine, 2021 - Springer
Background Long-term effects of COVID-19, also called Long COVID, affect more than 10%
of patients. The most severe cases (ie those requiring hospitalization) present a higher …
of patients. The most severe cases (ie those requiring hospitalization) present a higher …
[HTML][HTML] The role of cytokines and chemokines in severe acute respiratory syndrome coronavirus 2 infections
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in countless
infections and caused millions of deaths since its emergence in 2019. Coronavirus disease …
infections and caused millions of deaths since its emergence in 2019. Coronavirus disease …
[HTML][HTML] Post-COVID-19 pulmonary fibrosis: novel sequelae of the current pandemic
SR Ambardar, SL Hightower, NA Huprikar… - Journal of clinical …, 2021 - mdpi.com
Since the initial identification of the novel coronavirus SARS-CoV-2 in December 2019, the
COVID-19 pandemic has become a leading cause of morbidity and mortality worldwide. As …
COVID-19 pandemic has become a leading cause of morbidity and mortality worldwide. As …
The roles of critical pro‐inflammatory cytokines in the drive of cytokine storm during SARS‐CoV‐2 infection
In patients with severe COVID‐19, acute respiratory distress syndrome (ARDS), multiple
organ dysfunction syndrome (MODS), and even mortality can result from cytokine storm …
organ dysfunction syndrome (MODS), and even mortality can result from cytokine storm …
Pulmonary fibrosis secondary to COVID-19: a narrative review
ABSTRACT Introduction: Coronavirus disease 2019 (COVID-19) is still increasing
worldwide, and as a result, the number of patients with pulmonary fibrosis secondary to …
worldwide, and as a result, the number of patients with pulmonary fibrosis secondary to …
[HTML][HTML] Recovering from a pandemic: pulmonary fibrosis after SARS-CoV-2 infection
RJ Mylvaganam, JI Bailey, JI Sznajder… - European respiratory …, 2021 - Eur Respiratory Soc
Acute manifestations of SARS-CoV-2 infection continue to impact the lives of many across
the world. Post-acute sequelae of coronavirus disease 2019 (COVID-19) may affect 10–30 …
the world. Post-acute sequelae of coronavirus disease 2019 (COVID-19) may affect 10–30 …
Iron oxide nanoparticles augment the intercellular mitochondrial transfer–mediated therapy
T Huang, T Zhang, X Jiang, A Li, Y Su, Q Bian… - Science …, 2021 - science.org
The transfer of mitochondria between cells has recently been revealed as a spontaneous
way to protect the injured cells. However, the utilization of this natural transfer process for …
way to protect the injured cells. However, the utilization of this natural transfer process for …